跳至主要内容
临床试验/NCT03957668
NCT03957668Unknown3 期

Efficacy and Safety of PEG 3350 for Treatment of Chronic Constipation

Fakultas Kedokteran Universitas Indonesia3 个研究点 分布在 1 个国家目标入组 184 人开始时间: 2019年12月7日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
入组人数
184
试验地点
3
主要终点
Change of number of bowel movements at 1 week

研究概览

简要总结

The aim of this study is to determine the efficacy and safety of PEG 3350 (polyethylene glycol 3350) for short-term treatment of chronic constipation in adults.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males and females aged ≥ 18 years.
  • Body Mass Index (BMI) ≥ 18.5
  • Organic bowel disease will be ruled out by Fecal Immunochemical Test (FIT) and/or colonoscopy.
  • Must have ≤ 2 bowel movements during a 7-day qualification period.
  • In otherwise good health as judged by a physical examination and laboratory testing.
  • Not taking medications known to affect bowel function in one week before study.
  • Willing to participate in the study by signing the informed consent.

排除标准

  • Hypersensitive to the study medication.
  • obstructive ileus.
  • Irritable bowel syndrome (IBS) or inflammatory bowel disease (IBD)

研究组 & 干预措施

Lactulax

Active Comparator

15 ml of Lactulax syrup (containing 10 g of lactulose) is drunk with 240 ml of water once daily at bedtime, for a duration of 14 days

干预措施: Lactulose (Drug)

PEG 3350

Experimental

The content of each sachet of PEG 3350 (17 g powder) is dissolved in 240 mL of water, drink it once daily at bedtime, for a duration of 14 days.

干预措施: PEG 3350 (Drug)

结局指标

主要结局

Change of number of bowel movements at 1 week

时间窗: 7 days

An increase in the number of bowel movements (defecation) per 7-day period indicates a positive result.

Change of number of bowel movements at 2 weeks

时间窗: 14 days

An increase in the number of bowel movements (defecation) per 7-day period indicates a positive result.

次要结局

  • Symptom scores at 1 week(7 days)
  • Symptom scores at 2 weeks(14 days)
  • Overall rating of effectiveness at 1 week(7 days)
  • Overall rating of effectiveness at 2 weeks(14 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Murdani Abdullah

Professor

Fakultas Kedokteran Universitas Indonesia

研究点 (3)

Loading locations...

相似试验